tirzepatide fda changes vs. Semaglutide: What You Should Know Retatrutide vs Tirzepatide: The FDA's
Description
Tirzepatide is a once-weekly subcutaneous injection using a small needle similar to insulin
Anker, S
In clinical trials, gallstone formation occurred in 1.1-2.5% of tirzepatide users compared to 0-1% on placebo, depending on the study population
The powder cake may be compact or loose, flat or domed, pure white or slightly off-white
In concordance, there was no significant relationship between the exposure of tirzepatide and the CP score when assessed as a continuous variable
